Objective: Unicameral bone cyst is a nonneoplastic bone lesion characterized by its tenacity and risk of recurrence. Pathological
fracture is common and is often the presenting symptom. The objective of the present study was to evaluate the results of
hybrid external fixator for the treatment of a unicameral bone cyst with a pathological fracture. Methods: Hybrid external
fixator for the treatment of a unicameral bone cyst was performed in twelve patients. These patients presented with a pathological
fracture and were managed immediately with hybrid external fixator, of whom four had been managed conservatively at other
clinics before they were referred to our department. The cyst was located in the proximal humerus in all patients. The mean
age of the patients at the time of surgery was 8.7 years, and the mean duration of follow-up was 32.6 months. Radiographic
evaluation was performed according to the criteria of Capanna et al., and the cyst was classified as completely healed, healed
with residual radiolucency (osteolysis), recurred, or having no response. Results: The healing period ranged from three to
eight months. Eight cysts healed completely, and three healed with residual radiolucent areas visible on radiographs. There
was recurrence of one cyst that had healed with residual radiolucency. All of the cysts in the present study responded to
treatment. A modulation of hybrid external fixator was necessary in three patients, as the bars had become too short after
bone growth or the pins had been loose. No major complications were observed. Conclusion: Hybrid external fixator provides
early stability, which allows early mobilization and thus obviates the need for a plaster cast. This method of treatment also
allows for an early return to normal activity.
Key words Unicameral bone cyst - External fixator - Pathological fracture - Bone graft
CLC number R738.1
Biography: GUO Zheng (1965-), male, associate professor, doctor of medicine, Fourth Military Medical University, majors in the research
on surgery of bone and joint and bone malignant.